Our current studies demonstrate a high correlation between ZNF217 and ERα expression in breast cancer cell lines and breast tumor tissue, yet the precise role of ZNF217 in ER+ breast cancer is not fully understood. This evidence concerns the gene ESR1 and breast carcinoma.